Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Clinuvel Pharmaceuticals Limited
Pharmaceutical Preparation ManufacturingAustralia
Last verified 9 months agoclinuvel.com
Clinuvel Pharmaceuticals Limited, commonly referred to as Clinuvel, is an Australian-based company specialising in pharmaceutical preparation manufacturing. Headquartered in Melbourne, Australia, it operates across key regions including Europe and North America, focusing on developing innovative treatments for skin and light-sensitive conditions. Founded in 2000, Clinuvel has established a strong reputation for its pioneering work in photoprotection and dermatology.
The company's core products include SCENESSE®, a specialised drug designed to treat erythropoietic protoporphyria (EPP), and other advanced therapies targeting rare and severe skin disorders. What sets Clinuvel apart is its commitment to scientific research and personalised medicine, positioning it as a leader in the niche pharmaceutical market. With notable achievements in clinical development and regulatory approvals, Clinuvel continues to advance its mission to improve patient outcomes worldwide.
23
DitchCarbon score
-19 vs industry average
Clinuvel Pharmaceuticals Limited’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Clinuvel Pharmaceuticals Limited?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Clinuvel Pharmaceuticals Limited yet.
Clinuvel Pharmaceuticals Limited's reported carbon emissions
Clinuvel Pharmaceuticals Limited, an Australian pharmaceutical preparation manufacturer, does not publicly report its carbon emissions data. Therefore, specific Scope 1, 2, or 3 emissions figures are not available. The company has not announced any climate reduction targets or commitments, such as Science Based Targets (SBTi), nor is it a signatory to The Climate Pledge.
Assessing Clinuvel Pharmaceuticals Limited as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Clinuvel Pharmaceuticals Limited and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Clinuvel Pharmaceuticals Limited’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Clinuvel Pharmaceuticals Limited yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Clinuvel Pharmaceuticals Limited9 months ago
23
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more